Impact of the CYP2D6 phenotype on hyperprolactinemia development as an adverse event of treatment with atypical antipsychotic agents in pediatric patients.
Raluca GrădinaruNicoleta AndreescuLaura NussbaumLiana SuciuMaria PuiuPublished in: Irish journal of medical science (2019)
For the slow and intermediate metabolizers, atypical antipsychotics determined a significant increase of prolactinemia with high risk of adverse events.
Keyphrases